Please use this identifier to cite or link to this item:
Title: Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study
Author: Díaz Feijoo, Berta
Agusti Garcia, Nuria
Sebio, Raquel
López-Hernández, Antonio
Siso, Marina
Glickman, Ariel
Carreras Dieguez, Nuria
Fuste, Pere
Marina, Tiermes
Martínez-Egea, Judit
Aguilera, Laura
Perdomo, Juan
Pelaez, Amaia
López-Baamonde, Manuel
Navarro Ripoll, Ricard
Gimeno, Elena
Campero, Betina
Torné Bladé, Aureli
Martinez-Palli, Graciela
Arguis, María José
Keywords: Càncer d'ovari
Cirurgia ginecològica
Quimioteràpia del càncer
Malalts de càncer
Ovarian cancer
Gynecologic surgery
Cancer chemotherapy
Cancer patients
Issue Date: 23-Mar-2022
Publisher: MDPI
Abstract: Introduction: Treatment for advanced ovarian cancer (AOC) comprises cytoreductive surgery combined with chemotherapy. Multimodal prehabilitation programmes before surgery have demonstrated efficacy in postoperative outcomes in non-gynaecological surgeries. However, the viability and effects of these programmes on patients with AOC are unknown. We aimed to evaluate the feasibility and postoperative impact of a multimodal prehabilitation programme in AOC patients undergoing surgery. Methods: This single-centre, before-and-after intervention pilot study included 34 patients in two cohorts: the prehabilitation cohort prospectively included 15 patients receiving supervised exercise, nutritional optimisation, and psychological preparation from December 2019 to January 2021; the control cohort included 19 consecutive patients between January 2018 and November 2019. Enhanced Recovery After Surgery guidelines were followed. Results: The overall adherence to the multimodal prehabilitation programme was 80%, with 86.7% adherence to exercise training, 100% adherence to nutritional optimisation, and 80% adherence to psychological preparation. The median hospital stay was shorter in the prehabilitation cohort (5 (IQR, 4-6) vs. 7 days (IQR, 5-9) in the control cohort, p = 0.04). Differences in postoperative complications using the comprehensive complication index (CCI) were not significant (CCI score: 9.3 (SD 12.12) in the prehabilitation cohort vs. 16.61 (SD 16.89) in the control cohort, p = 0.08). The median time to starting chemotherapy was shorter in the prehabilitation cohort (25 (IQR, 23-25) vs. 35 days (IQR, 28-45) in the control cohort, p = 0.03). Conclusions: A multimodal prehabilitation programme before cytoreductive surgery is feasible in AOC patients with no major adverse effects, and results in significantly shorter hospital stays and time to starting chemotherapy.
Note: Reproducció del document publicat a:
It is part of: Cancers, 2022, vol. 14, num. 7, p. 1635
Related resource:
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
724414.pdf2.08 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons